Literature DB >> 1974712

Depletion of catecholamines in the brain of rats differentially affects stimulation of locomotor activity by caffeine, D-amphetamine, and methylphenidate.

I B Finn1, P M Iuvone, S G Holtzman.   

Abstract

The purpose of this study was to assess the role of catecholamines in brain, in the stimulation of locomotor activity, induced by caffeine, as compared to the psychomotor stimulants D-amphetamine and methylphenidate. Adult male rats were pretreated with either (1) 2.5 mg/kg (i.p.) reserpine, 24 hr prior to testing of locomotor activity, (2) 50 mg/kg (i.p.) alpha-methyl-para-tyrosine (AMPT) 6 hr and 2 hr prior to testing of locomotor activity, (3) 200 micrograms/rat (i.c.v.) 6-hydroxydopamine (6-OHDA), or 25 mg/kg (i.p.) desmethylimipramine (DMI) and 200 micrograms/rat 6-OHDA (i.c.v.), 6-8 weeks prior to testing. Each treatment group had a matched control group. Levels of catecholamines in the forebrain were determined in each of the treatment and corresponding control groups. All rats were tested with doses of caffeine, D-amphetamine and methylphenidate (excluding the 6-OHDA-treated animals), administered in random order intraperitoneally 35 min before locomotor activity was measured for 30 min. Pretreatment with either reserpine or AMPT attenuated the stimulation of locomotor activity induced by caffeine and D-amphetamine but not that induced by methylphenidate. The dose-response curve for amphetamine was shifted downward and to the right by reserpine but was flattened by AMPT. The dose-response curve for caffeine was displaced downward in a similar manner by both reserpine and AMPT. Treatment with 6-OHDA or DMI + 6-OHDA produced the expected changes in the content of catecholamines in brain, but failed to modify dose-response curves for caffeine or amphetamine.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1974712     DOI: 10.1016/0028-3908(90)90023-k

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  13 in total

1.  The partial D2-like dopamine receptor agonist terguride acts as a functional antagonist in states of high and low dopaminergic tone: evidence from preweanling rats.

Authors:  Sanders A McDougall; Rita M Hernandez; Carmela M Reichel; Cristal M Farley
Journal:  Psychopharmacology (Berl)       Date:  2004-11-18       Impact factor: 4.530

2.  Effects of dopamine uptake inhibitor MRZ-9547 in animal models of Parkinson's disease.

Authors:  Andrzej Dekundy; Flora Mela; Martine Hofmann; Wojciech Danysz
Journal:  J Neural Transm (Vienna)       Date:  2014-10-16       Impact factor: 3.575

3.  The stimulant effects of caffeine on locomotor behaviour in mice are mediated through its blockade of adenosine A(2A) receptors.

Authors:  M El Yacoubi; C Ledent; J F Ménard; M Parmentier; J Costentin; J M Vaugeois
Journal:  Br J Pharmacol       Date:  2000-04       Impact factor: 8.739

4.  Activation of metabotropic glutamate 2/3 receptors attenuates methamphetamine-induced hyperlocomotion and increase in prefrontal serotonergic neurotransmission.

Authors:  Yukio Ago; Ryota Araki; Koji Yano; Naoki Hiramatsu; Toshiyuki Kawasaki; Shigeyuki Chaki; Atsuro Nakazato; Hirotaka Onoe; Hitoshi Hashimoto; Akemichi Baba; Kazuhiro Takuma; Toshio Matsuda
Journal:  Psychopharmacology (Berl)       Date:  2011-04-13       Impact factor: 4.530

5.  MK801-induced locomotor activity in preweanling and adolescent male and female rats: role of the dopamine and serotonin systems.

Authors:  Sanders A McDougall; Matthew G Apodaca; Ginny I Park; Angie Teran; Timothy J Baum; Nazaret R Montejano
Journal:  Psychopharmacology (Berl)       Date:  2020-05-22       Impact factor: 4.530

6.  Effects of monoamine depletion on the ketamine-induced locomotor activity of preweanling, adolescent, and adult rats: Sex and age differences.

Authors:  Cynthia A Crawford; Andrea E Moran; Timothy J Baum; Matthew G Apodaca; Nazaret R Montejano; Ginny I Park; Vanessa Gomez; Sanders A McDougall
Journal:  Behav Brain Res       Date:  2019-10-05       Impact factor: 3.332

7.  Caffeine reversal of sleep deprivation effects on alertness and mood.

Authors:  D Penetar; U McCann; D Thorne; G Kamimori; C Galinski; H Sing; M Thomas; G Belenky
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

8.  The stimulatory effect of clonidine through imidazoline receptors on locus coeruleus noradrenergic neurones is mediated by excitatory amino acids and modulated by serotonin.

Authors:  J A Ruiz-Ortega; L Ugedo; J Pineda; J A García-Sevilla
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-08       Impact factor: 3.000

Review 9.  Pharmacological rationale for the clinical use of caffeine.

Authors:  J Sawynok
Journal:  Drugs       Date:  1995-01       Impact factor: 9.546

10.  Reduced presynaptic dopamine activity in adolescent dorsal striatum.

Authors:  Marguerite Matthews; Corina Bondi; Gonzalo Torres; Bita Moghaddam
Journal:  Neuropsychopharmacology       Date:  2013-01-28       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.